[go: up one dir, main page]

HK1220114B - 用於治疗癌症的氧烯洛尔组合物 - Google Patents

用於治疗癌症的氧烯洛尔组合物 Download PDF

Info

Publication number
HK1220114B
HK1220114B HK16108117.3A HK16108117A HK1220114B HK 1220114 B HK1220114 B HK 1220114B HK 16108117 A HK16108117 A HK 16108117A HK 1220114 B HK1220114 B HK 1220114B
Authority
HK
Hong Kong
Prior art keywords
oxprenolol
cancer
composition
individual
pharmaceutically acceptable
Prior art date
Application number
HK16108117.3A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1220114A1 (zh
Inventor
安德鲁．J．S．科茨
斯特凡．安柯
约翰恩．斯普林格
Original Assignee
Actimed Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actimed Therapeutics Ltd filed Critical Actimed Therapeutics Ltd
Priority claimed from PCT/AU2014/000266 external-priority patent/WO2014138806A1/en
Publication of HK1220114A1 publication Critical patent/HK1220114A1/zh
Publication of HK1220114B publication Critical patent/HK1220114B/zh

Links

HK16108117.3A 2013-03-14 2014-03-14 用於治疗癌症的氧烯洛尔组合物 HK1220114B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786241P 2013-03-14 2013-03-14
US201361786241P 2013-03-14
PCT/AU2014/000266 WO2014138806A1 (en) 2013-03-14 2014-03-14 Oxprenolol compositions for treating cancer

Publications (2)

Publication Number Publication Date
HK1220114A1 HK1220114A1 (zh) 2017-04-28
HK1220114B true HK1220114B (zh) 2019-08-30

Family

ID=

Similar Documents

Publication Publication Date Title
US11433036B2 (en) Oxprenolol compositions for treating cancer
US20110160295A1 (en) Antitumor agent
CN106999462B (zh) 包含选择性s1p1受体激动剂的药物组合物
CN101600426B (zh) 用于治疗肠道疾病的异山梨醇单硝酸酯衍生物
US20260027088A1 (en) Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer
EP2968227B1 (en) S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
US10358447B2 (en) Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same
EP4151221A1 (en) Combination comprising tricycle compound and use thereof in preparation of medicament for treating hbv
WO2020249120A9 (zh) 氨基硫醇类化合物作为脑神经或心脏保护剂的用途
HK1220114B (zh) 用於治疗癌症的氧烯洛尔组合物
WO2024007801A1 (zh) 受体酪氨酸激酶抑制剂与联苯环辛二稀木脂素的联合用药及其用途
ES2672326T3 (es) Analogos de tiazolidinona deuterados como agonistas para el receptor de la hormona folículo estimulante
WO2014138802A1 (en) Canrenoate compositions for treating cancer
US10058618B2 (en) PAK1-blocking 1,2,3-triazolyl esters
JP2025503215A (ja) Ｎｔｓｒ１標的化放射性医薬品およびｄｎａ損傷応答阻害剤併用療法
HK1220609B (zh) 一种用於治疗肌萎缩性侧索硬化症的β受体阻滞剂的S-对映体富集组合物